Page last updated: 2024-10-21

1,3-dipropyl-8-cyclopentylxanthine and Pick Disease of the Brain

1,3-dipropyl-8-cyclopentylxanthine has been researched along with Pick Disease of the Brain in 1 studies

DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.

Pick Disease of the Brain: A rare form of DEMENTIA that is sometimes familial. Clinical features include APHASIA; APRAXIA; CONFUSION; ANOMIA; memory loss; and personality deterioration. This pattern is consistent with the pathologic findings of circumscribed atrophy of the poles of the FRONTAL LOBE and TEMPORAL LOBE. Neuronal loss is maximal in the HIPPOCAMPUS, entorhinal cortex, and AMYGDALA. Some ballooned cortical neurons contain argentophylic (Pick) bodies. (From Brain Pathol 1998 Apr;8(2):339-54; Adams et al., Principles of Neurology, 6th ed, pp1057-9)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albasanz, JL1
Rodríguez, A1
Ferrer, I1
Martín, M1

Other Studies

1 other study available for 1,3-dipropyl-8-cyclopentylxanthine and Pick Disease of the Brain

ArticleYear
Up-regulation of adenosine A1 receptors in frontal cortex from Pick's disease cases.
    The European journal of neuroscience, 2007, Volume: 26, Issue:12

    Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Aged; Bra

2007